We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+28.89%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$4.87B
AUM Growth
+$760M
Cap. Flow
-$2.18M
Cap. Flow %
-0.04%
Top 10 Hldgs %
26.33%
Holding
479
New
108
Increased
120
Reduced
143
Closed
93

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$80.3M
2
AMD icon
Advanced Micro Devices
AMD
+$63M
3
U icon
Unity
U
+$41.2M
4
RLAY icon
Relay Therapeutics
RLAY
+$40.9M
5
RIO icon
Rio Tinto
RIO
+$37.9M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Consumer Discretionary 22.8%
3 Healthcare 20.94%
4 Financials 8.5%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUV icon
326
Southwest Airlines
LUV
$24.1B
$529K 0.01%
+14,100
New +$501K
QDEL icon
327
QuidelOrtho
QDEL
$1.18B
$529K 0.01%
+2,413
New +$538K
ALNY icon
328
Alnylam Pharmaceuticals
ALNY
$30.5B
$523K 0.01%
3,590
+438
+14% +$62.2K
FND icon
329
Floor & Decor
FND
$6.62B
$522K 0.01%
6,978
+2,904
+71% +$199K
BTAI icon
330
BioXcel Therapeutics
BTAI
$26.9M
$520K 0.01%
750
-16,954
-96% -$12.7M
DKNG icon
331
DraftKings
DKNG
$10.9B
$518K 0.01%
8,800
-43,900
-83% -$1.71M
BILI icon
332
Bilibili
BILI
$7.73B
$498K 0.01%
+11,980
New +$529K
STIM icon
333
Neuronetics
STIM
$159M
$486K 0.01%
+100,000
New +$379K
ZG icon
334
Zillow
ZG
$8.42B
$486K 0.01%
+4,784
New +$372K
MSCI icon
335
MSCI
MSCI
$41.5B
$472K 0.01%
1,323
+159
+14% +$57.7K
COGT icon
336
Cogent Biosciences
COGT
$7.27B
$468K 0.01%
+50,000
New +$521K
J icon
337
Jacobs Solutions
J
$16.9B
$462K 0.01%
6,021
BIOR
338
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$451K 0.01%
+200
New +$452K
MEDP icon
339
Medpace
MEDP
$16.2B
$449K 0.01%
+4,022
New +$465K
DDOG icon
340
Datadog
DDOG
$102B
$448K 0.01%
4,382
+529
+14% +$46K
GGG icon
341
Graco
GGG
$13.3B
$448K 0.01%
+7,299
New +$408K
POOL icon
342
Pool Corp
POOL
$7.48B
$439K 0.01%
1,311
+541
+70% +$167K
CPSR.U
343
DELISTED
Capstar Special Purpose Acquisition Corp. Units, each consisting of one share of Class A Common Stoc
CPSR.U
$437K 0.01%
+42,857
New +$436K
PDFS icon
344
PDF Solutions
PDFS
$2.1B
$430K 0.01%
23,000
-14,000
-38% -$288K
TTC icon
345
Toro Company
TTC
$9.46B
$425K 0.01%
5,059
+1,701
+51% +$127K
PEN icon
346
Penumbra
PEN
$12.7B
$417K 0.01%
2,143
-679
-24% -$143K
MKSI icon
347
MKS Inc
MKSI
$21.7B
$399K 0.01%
3,652
+41
+1% +$4.8K
TMO icon
348
Thermo Fisher Scientific
TMO
$213B
$391K 0.01%
+886
New +$366K
RACE icon
349
Ferrari
RACE
$71.4B
$373K 0.01%
2,026
CARR icon
350
Carrier Global
CARR
$53.9B
$371K 0.01%
12,155
+1,512
+14% +$42.8K

Similar funds

Driehaus Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Driehaus Capital Management held 479 positions worth $4.87B, up 18% from $4.11B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Driehaus Capital Management's Q3 2020 filing shows 108 new, 120 increased, 143 reduced and 93 closed positions. Its largest new stake was Nike: 748,402 shares worth $94M. The largest sale was Alibaba, an estimated $77.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Driehaus Capital Management's largest Q3 2020 buy was Nike: 748,402 shares worth $94M.
  • Driehaus Capital Management added most to Advanced Micro Devices in Q3 2020, an estimated $63M increase.
  • Driehaus Capital Management's biggest Q3 2020 reduction was Alibaba, cutting an estimated $77.1M.
  • Driehaus Capital Management fully exited Analog Devices in Q3 2020, selling an estimated $43.3M.
  • Driehaus Capital Management's ten largest holdings make up 26% of its $4.87B portfolio in Q3 2020.
  • Driehaus Capital Management opened 108 new positions and closed 93 in Q3 2020.
  • Driehaus Capital Management's portfolio value rose 18% quarter-over-quarter to $4.87B.

Based on Driehaus Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.